DE19700134A1 - Immundissoziation zur Verbesserung der immunchemischen Bestimmung eines Analyten - Google Patents

Immundissoziation zur Verbesserung der immunchemischen Bestimmung eines Analyten

Info

Publication number
DE19700134A1
DE19700134A1 DE19700134A DE19700134A DE19700134A1 DE 19700134 A1 DE19700134 A1 DE 19700134A1 DE 19700134 A DE19700134 A DE 19700134A DE 19700134 A DE19700134 A DE 19700134A DE 19700134 A1 DE19700134 A1 DE 19700134A1
Authority
DE
Germany
Prior art keywords
analyte
directed
antibody
receptor
immobilized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19700134A
Other languages
German (de)
English (en)
Inventor
Stefan Dr Brust
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Dade Behring Marburg GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Behring Marburg GmbH filed Critical Dade Behring Marburg GmbH
Priority to DE19700134A priority Critical patent/DE19700134A1/de
Priority to DE59712575T priority patent/DE59712575D1/de
Priority to AT97120361T priority patent/ATE317979T1/de
Priority to EP97120361A priority patent/EP0849596B1/de
Priority to US08/992,007 priority patent/US5989806A/en
Priority to CA002225078A priority patent/CA2225078A1/en
Priority to KR1019970069469A priority patent/KR19980064214A/ko
Priority to JP9348384A priority patent/JPH10197531A/ja
Publication of DE19700134A1 publication Critical patent/DE19700134A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G01N2333/162—HIV-1, HIV-2 env, e.g. gp160, gp110/120, gp41, V3, peptid T, DC4-Binding site

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • AIDS & HIV (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
DE19700134A 1996-12-19 1997-01-03 Immundissoziation zur Verbesserung der immunchemischen Bestimmung eines Analyten Withdrawn DE19700134A1 (de)

Priority Applications (8)

Application Number Priority Date Filing Date Title
DE19700134A DE19700134A1 (de) 1996-12-19 1997-01-03 Immundissoziation zur Verbesserung der immunchemischen Bestimmung eines Analyten
DE59712575T DE59712575D1 (de) 1996-12-19 1997-11-20 Immundissoziation zur Verbesserung der immunchemischen Bestimmung eines Analyten
AT97120361T ATE317979T1 (de) 1996-12-19 1997-11-20 Immundissoziation zur verbesserung der immunchemischen bestimmung eines analyten
EP97120361A EP0849596B1 (de) 1996-12-19 1997-11-20 Immundissoziation zur Verbesserung der immunchemischen Bestimmung eines Analyten
US08/992,007 US5989806A (en) 1996-12-19 1997-12-17 Immunodissociation for improving the immunochemical determination of an analyte
CA002225078A CA2225078A1 (en) 1996-12-19 1997-12-17 Immunodissociation for improving the immunochemical determination of an analyte
KR1019970069469A KR19980064214A (ko) 1996-12-19 1997-12-17 분석물의 면역화학적 측정을 개선하기 위한 면역해리법
JP9348384A JPH10197531A (ja) 1996-12-19 1997-12-18 被検物質の免疫化学的測定の改良のための免疫解離

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19653074 1996-12-19
DE19700134A DE19700134A1 (de) 1996-12-19 1997-01-03 Immundissoziation zur Verbesserung der immunchemischen Bestimmung eines Analyten

Publications (1)

Publication Number Publication Date
DE19700134A1 true DE19700134A1 (de) 1998-08-06

Family

ID=7815399

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19700134A Withdrawn DE19700134A1 (de) 1996-12-19 1997-01-03 Immundissoziation zur Verbesserung der immunchemischen Bestimmung eines Analyten

Country Status (2)

Country Link
KR (1) KR19980064214A (ko)
DE (1) DE19700134A1 (ko)

Also Published As

Publication number Publication date
KR19980064214A (ko) 1998-10-07

Similar Documents

Publication Publication Date Title
EP0849596B1 (de) Immundissoziation zur Verbesserung der immunchemischen Bestimmung eines Analyten
EP0944838B1 (de) ANTIGENSPEZIFISCHER IgG-NACHWEIS
EP0944832B1 (de) ANTIGENSPEZIFISCHER IgM-NACHWEIS
EP0825441B1 (de) Sensitivitätssteigerung bei der immunchemischen Bestimmung eines Analyten
DE69622696T2 (de) Zellzählung durch einen immunoassay
DE68922243T2 (de) Immuntest für HIV-1-Antigene unter Benutzung von F(AB')2-Fragmenten als Sonde.
DE3209149A1 (de) Verfahren zur gemeinsamen immunologischen bestimmung von prokollagen-peptid (typ iii) und prokollagen-peptid col 1 (typ iii) und verfahren zur herstellung von anti-prokollagen-peptid col 1 (typ iii)-serum
EP0882985B1 (de) Immunchemische Bestimmung von multivalenten Analyten
EP0703452A2 (de) Verfahren zum qualitativen und/oder quantitativen Nachweis einer zu bestimmenden Substanz
EP0829723B1 (de) Homogene Nachweisverfahren zur Bestimmung von Subpopulationen eines Analyten
EP0572845B1 (de) Verfahren zur immunchemischen Bestimmung eines Analyten
DE19920704C1 (de) Verwendung eines gegen Harn-Trypsin-Inhibitors gerichteten Antikörpers für die Diagnose des Ausbruchs von AIDS
DE3854834T2 (de) Immuntest unter Verwendung von Antigenen, produziert in heterologen Organismen
DE69529787T2 (de) Testsatz und Methode für eine Bestimmung durch kompetitive spezifische Bindung
DE19700134A1 (de) Immundissoziation zur Verbesserung der immunchemischen Bestimmung eines Analyten
DE69632535T2 (de) Peptide zur detektion von hiv-1
EP0781998B1 (de) Immunologische Bestimmungsmethode
EP0583689B1 (de) Immunchemisches Verfahren zum Nachweis eines Analyten
EP0557546A1 (de) Kopplung von Antigenen und Antikörpern an nicht-fixierte Erythrozyten
DE69008712T2 (de) Hiv p17-test für die überwachung des verlaufs von aids.
EP1568996B1 (de) Verbesserung von Bindeassays durch Multiepitopanalyse und Kombination von Antigen- und Antikörper- Bestimmung
EP1382967B1 (de) Verfahren und Diagnostikum zum qualitativen oder quantitativen Nachweis von Antikörpern und zur Bestimmung von deren Avidität
EP1159621B1 (de) Verfahren zur bestimmung der avidität von antikörpern
EP1090298B1 (de) Verbesserung von bindeassays durch multiepitopanalyse
DE4236189A1 (de) Verfahren zur simultanen Bestimmung von Antigenen und Antikörpern

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8130 Withdrawal